Status:
COMPLETED
A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Ovarian Neoplasms
Breast Neoplasms
Eligibility:
FEMALE
18+ years
Brief Summary
The objective of this trial is to study the management of PPE in participants with metastatic ovarian or breast cancer treated with Caelyx, and determine the frequency of use of pharmacological treatm...
Eligibility Criteria
Inclusion
- Women 18 years of age or older.
- Participants with metastatic breast or ovarian cancer who are receiving treatment with pegylated liposomal doxorubicin.
- Participants who have given their written consent.
Exclusion
- Participants who are currently participating in a clinical trial.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT00746694
Start Date
October 1 2007
End Date
June 1 2009
Last Update
August 27 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.